Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Patients With Anemia of Non-dialysis Chronic Kidney Diseases.

NCT04470063 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia Associated Chronic Kidney Disease

Interventions

DRUG: DDO-3055 tablets
DRUG: Placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.